Option Care Health (OPCH) Stock Price, News & Analysis

Company Overview

Option Care Health, Inc. is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion centers and other outpatient locations.

Its services include pharmacy and nursing support for intravenous and subcutaneous therapies, care coordination, patient education, clinical monitoring and reimbursement assistance. Option Care Health supports treatment for a range of acute and chronic conditions, including immune deficiencies, infections, gastrointestinal disorders, neurological conditions, bleeding disorders and other diseases requiring specialty pharmaceuticals or parenteral nutrition.

The company operates a nationwide network of pharmacies, infusion suites and clinical teams serving patients across the United States. Option Care Health was formed through the 2019 merger of Option Care and BioScrip, combining their home infusion operations. John C. Rademacher serves as president and chief executive officer.

Key Stats

• Today's Range: $23.23 to $23.90
• 50-Day Range: $21.08 to $24.50
• 52-Week Range: $18.01 to $36.80
• Volume: 719,440 shs
• Average Volume: 2.44 million shs
• Market Capitalization: $3.61 billion
• P/E Ratio: 18.10
• Dividend Yield: N/A
• Price Target: $29.92
• Consensus Rating: Moderate Buy

Option Care Health Stock Analysis - MarketRank™

Option Care Health scored higher than 73% of companies evaluated by MarketBeat, and ranked 193rd out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Option Care Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 7 buy ratings, 7 hold ratings, and no sell ratings.

Upside Potential

Option Care Health has a consensus price target of $29.92, representing about 26.2% upside from its current price of $23.70.

Amount of Analyst Coverage

Option Care Health has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 11.24%

Earnings Growth

Earnings for Option Care Health are expected to grow by 11.24% in the coming year, from $1.69 to $1.88 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Option Care Health is 17.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.93.

Price to Earnings Ratio vs. Sector

The P/E ratio of Option Care Health is 17.79, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.55.

Price to Earnings Growth Ratio

Option Care Health has a PEG Ratio of 1.39. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Option Care Health has a P/B Ratio of 2.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.60% of the float of Option Care Health has been sold short.

Short Interest Ratio / Days to Cover

Option Care Health has a short interest ratio ("days to cover") of 7.25.

Change versus previous month

Short interest in Option Care Health has recently increased by 5.19%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Option Care Health does not currently pay a dividend.

Dividend Growth

Option Care Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.63

News Sentiment

Option Care Health has a news sentiment score of 1.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Option Care Health this week, compared to 4 articles on an average week.

Search Interest

Only 1 people have searched for OPCH on MarketBeat in the last 30 days. This is a decrease of -91% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Option Care Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Option Care Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.70% of the stock of Option Care Health is held by insiders.

Percentage Held by Institutions

98.05% of the stock of Option Care Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 9/16/2026
• Next Earnings (Estimated): 10/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:OPCH
• CIK: 1014739
• Web: www.optioncarehealth.com
• Phone: (312) 940-2443
• Fax: 952-979-3969
• Employees: 8,266
• Year Founded: 1979

Price Target and Rating

• Average Price Target for Option Care Health: $29.92
• High Price Target: $39.00
• Low Price Target: $22.00
• Potential Upside/Downside: +25.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.33
• Trailing P/E Ratio: 17.96
• Forward P/E Ratio: 14.13
• P/E Growth: 1.39
• Net Income: $207.59 million
• Net Margins: 3.68%
• Pretax Margin: 5.01%
• Return on Equity: 18.74%
• Return on Assets: 7.25%

Debt

• Debt-to-Equity Ratio: 0.91
• Current Ratio: 1.47
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $5.65 billion
• Price / Sales: 0.63
• Cash Flow: $2.03 per share
• Price / Cash Flow: 11.74
• Book Value: $8.36 per share
• Price / Book: 2.86

Miscellaneous

• Outstanding Shares: 149,790,000
• Free Float: 147,239,000
• Market Cap: $3.58 billion
• Optionable: Optionable
• Beta: 0.61